DuPont aca III performance as tested according to NCCLS guidelines.

Area of Science:

• Clinical chemistry
• Laboratory instrumentation
• Analytical chemistry

Background:

• The DuPont aca III is a new microprocessor-controlled clinical chemistry analyzer.
• Evaluating new laboratory instruments is crucial for ensuring reliable diagnostic testing.
• Established guidelines from the National Committee for Clinical Laboratory Standards (NCCLS) provide a framework for performance evaluation.

Purpose of the Study:

• To assess the analytical performance of the DuPont aca III analyzer.
• To compare the aca III's performance against its predecessor, the aca II, and other established methods.
• To determine the precision and accuracy of the aca III across multiple analytical channels.

Main Methods:

• Analytical performance was evaluated using NCCLS draft guidelines (PSEP-2, 3, and 4).
• Precision was assessed through a 20-day replication study, estimating various standard deviations.
• Accuracy was determined by comparing aca III results with the aca II, atomic absorption spectroscopy (for calcium), and the National Glucose Reference Method.

Main Results:

• Estimated within-run, between-run, and total standard deviations were small across three concentrations.
• Bias and total error were calculated from duplicate analyses of 100 samples.
• Regression analysis indicated minimal deviation from reference methods, with small estimated errors.

Conclusions:

• The DuPont aca III exhibits acceptable analytical performance for clinical laboratory use.
• The instrument's precision and accuracy meet the evaluated performance criteria.
• The new aca III represents a reliable advancement in clinical diagnostic instrumentation.